Lupin received USFDA approval for Meclizine Hcl Tablets USP:
The Lupin’s Goa manufacturing facility receives an Abbreviated New Drug Application (ANDA) USFDA approval for Meclizine Hydrochloride tablets USP.
The product has received approval for different strengths, 12.5mg, 25mg, and 50 mg. The Lupin’s Goa facility is going to manufacture the product.
The product is a generic version of Antivert Tablets of 12.5, 25mg and 50mg of Casper Pharma.
Also Read:
- Impurities in drug substances in pharma
- What is Phase 1 clinical trial in pharma?
- What is Difference between assay, potency and purity?
- Why Data integrity important in pharma?
- How to prepare 0.1N HCl in pharma
- HPLC Calibration Parameters in pharma
YT channel: Pharmabeejpro